Breast cancer survivors: Assessment and management of long-term treatment effects
The number of new breast cancer cases is relatively stable (breast cancer represents 15% of all new cancer cases diagnosed in the United States…
Breast Cancer
Breast cancer treatment game changer?
A friend of mine has a daughter who’s expecting her second child and was just diagnosed with breast cancer. She’s currently undergoing low-dose chemotherapy…
Number of women living with metastatic breast cancer growing
The number of women living with metastatic breast cancer increased by 4% from 1990 to 2000 and by 17% from 2000 to 2010, according…
Radiation for older women with breast cancer
More than half of older women with early stage breast cancer receive more radiation therapy than what might be medically necessary and following evidence-based…
New guidelines for managing care of breast cancer survivors
The American Cancer Society and the American Society of Clinical Oncology have released a new Breast Cancer Survivorship Care Guideline to help breast cancer…
False-positive mammograms may indicate increased risk for breast cancer later in life
Women with a history of a false-positive mammogram result may be at increased risk of developing breast cancer for up to 10 years after…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
Breast cancer care gets personal
Learning objectives 1. State how breast cancer is diagnosed and evaluated. 2. Identify the implications of genetics for patients with breast cancer. 3. Discuss…
The elusive cure
Supporting breast cancer research and screening can help us get another step closer to curing this disease.
Make your health a priority.
May 11-17 marks National Women’s Health Week. ANA supports this effort to motivate women to make their own health a priority.
FDA expands Zytiga’s use for late-stage breast cancer
On Dec. 10, the U.S. Food and Drug Administration expanded the approved use of Zytiga (abiraterone acetate) to treat men with metastatic castration-resistant prostate…
Anastrozole and fulvestrant combination effective in metastatic breast cancer
The combination of anastrozole and fulvestrant was more effective than anastrozole alone or sequential anastrozole and fulvestrant for the treatment of hormone receptor-positive metastatic…
Breast cancer survivors: Assessment and management of long-term treatment effects
The number of new breast cancer cases is relatively stable (breast cancer represents 15% of all new cancer cases diagnosed in the…
Breast cancer treatment game changer?
A friend of mine has a daughter who’s expecting her second child and was just diagnosed with breast cancer. She’s currently undergoing…
Number of women living with metastatic breast cancer growing
The number of women living with metastatic breast cancer increased by 4% from 1990 to 2000 and by 17% from 2000 to…
Radiation for older women with breast cancer
More than half of older women with early stage breast cancer receive more radiation therapy than what might be medically necessary and…
New guidelines for managing care of breast cancer survivors
The American Cancer Society and the American Society of Clinical Oncology have released a new Breast Cancer Survivorship Care Guideline to help…
False-positive mammograms may indicate increased risk for breast cancer later in life
Women with a history of a false-positive mammogram result may be at increased risk of developing breast cancer for up to 10…
FDA approves Ibrance for postmenopausal women with metastatic breast cancer
On February 3, the U.S. Food and Drug Administration (FDA) approved Ibrance (palbociclib) to treat advanced metastatic breast cancer. Read more.
Breast cancer care gets personal
Learning objectives 1. State how breast cancer is diagnosed and evaluated. 2. Identify the implications of genetics for patients with breast cancer.…
The elusive cure
Supporting breast cancer research and screening can help us get another step closer to curing this disease.
Make your health a priority.
May 11-17 marks National Women’s Health Week. ANA supports this effort to motivate women to make their own health a priority.
FDA expands Zytiga’s use for late-stage breast cancer
On Dec. 10, the U.S. Food and Drug Administration expanded the approved use of Zytiga (abiraterone acetate) to treat men with metastatic…
Anastrozole and fulvestrant combination effective in metastatic breast cancer
The combination of anastrozole and fulvestrant was more effective than anastrozole alone or sequential anastrozole and fulvestrant for the treatment of hormone…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.